Christina Andreou1, Kristina Veith1, Vasilis P Bozikas2, Tania M Lincoln3, Steffen Moritz1. 1. The University Medical Center Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany. 2. 1st Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece. 3. The Department of Psychology, University of Hamburg, Hamburg, Germany.
Abstract
BACKGROUND: Enhanced automatic spreading of activation in the semantic network has been suggested to underlie formal thought disorder in patients with schizophrenia, but it is not clear how this relates to the dopaminergic dysfunction implicated in the disorder. Previous studies on dopaminergic modulation of priming in healthy volunteers have focused on controlled rather than automatic processes. The present study aimed to examine the effects of both a dopaminergic agonist and a dopaminergic antagonist on semantic priming while minimizing the contribution of controlled processes. METHODS: We investigated the effects of levodopa (L-Dopa; 100 mg), haloperidol (2 mg) and placebo on priming in healthy participants within a randomized, double-blind, crossover design. We used a pronunciation priming task with word triplets; the middle word was an ambiguous word, whereas the first word of the triplet served to provide either a congruent, incongruent or unbiased context for the target word. Two stimulus onset asynchronies (SOA) were used: 150 ms and 750 ms. RESULTS: The study involved 34 participants. At an SOA of 150 ms, L-Dopa accelerated responses to incongruent targets and subordinate targets of ambiguous words, whereas haloperidol was associated with faster responses in congruent contexts and dominant targets. At an SOA of 750 ms, haloperidol accelerated responses to subordinate targets. LIMITATIONS: Modulations in the relative magnitude of priming according to substance and condition rather than absolute priming were assessed. CONCLUSION: Effects of L-Dopa on automatic priming processes appear to be different than those on controlled processes. Our results are consistent with those of studies on semantic priming and the effects on antipsychotics in patients with schizophrenia.
RCT Entities:
BACKGROUND: Enhanced automatic spreading of activation in the semantic network has been suggested to underlie formal thought disorder in patients with schizophrenia, but it is not clear how this relates to the dopaminergic dysfunction implicated in the disorder. Previous studies on dopaminergic modulation of priming in healthy volunteers have focused on controlled rather than automatic processes. The present study aimed to examine the effects of both a dopaminergic agonist and a dopaminergic antagonist on semantic priming while minimizing the contribution of controlled processes. METHODS: We investigated the effects of levodopa (L-Dopa; 100 mg), haloperidol (2 mg) and placebo on priming in healthy participants within a randomized, double-blind, crossover design. We used a pronunciation priming task with word triplets; the middle word was an ambiguous word, whereas the first word of the triplet served to provide either a congruent, incongruent or unbiased context for the target word. Two stimulus onset asynchronies (SOA) were used: 150 ms and 750 ms. RESULTS: The study involved 34 participants. At an SOA of 150 ms, L-Dopa accelerated responses to incongruent targets and subordinate targets of ambiguous words, whereas haloperidol was associated with faster responses in congruent contexts and dominant targets. At an SOA of 750 ms, haloperidol accelerated responses to subordinate targets. LIMITATIONS: Modulations in the relative magnitude of priming according to substance and condition rather than absolute priming were assessed. CONCLUSION: Effects of L-Dopa on automatic priming processes appear to be different than those on controlled processes. Our results are consistent with those of studies on semantic priming and the effects on antipsychotics in patients with schizophrenia.
Authors: Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon Journal: J Neurosci Date: 2009-06-03 Impact factor: 6.167
Authors: Anthony J Angwin; Helen J Chenery; David A Copland; Wendy L Arnott; Bruce E Murdoch; Peter A Silburn Journal: J Int Neuropsychol Soc Date: 2004-01 Impact factor: 2.892
Authors: Ruth Condray; Greg J Siegle; Jonathan D Cohen; Daniel P van Kammen; Stuart R Steinhauer Journal: Biol Psychiatry Date: 2003-12-01 Impact factor: 13.382
Authors: Christina Andreou; Brooke C Schneider; Vivien Braun; Katharina Kolbeck; Jürgen Gallinat; Steffen Moritz Journal: J Psychiatry Neurosci Date: 2015-11 Impact factor: 6.186
Authors: Vitor C Zimmerer; Stuart Watson; Douglas Turkington; I Nicol Ferrier; Wolfram Hinzen Journal: Front Psychiatry Date: 2017-02-10 Impact factor: 4.157